S

Sun Pharma Advanced Research Co Ltd
NSE:SPARC

Watchlist Manager
Sun Pharma Advanced Research Co Ltd
NSE:SPARC
Watchlist
Price: 168.09 INR 1.38% Market Closed
Market Cap: 54.5B INR

Intrinsic Value

The intrinsic value of one SPARC stock under the Base Case scenario is 1 382.17 INR. Compared to the current market price of 168.09 INR, Sun Pharma Advanced Research Co Ltd is Undervalued by 88%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SPARC Intrinsic Value
1 382.17 INR
Undervaluation 88%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation History
Sun Pharma Advanced Research Co Ltd

Valuation History Unavailable

Historical valuation for SPARC cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare SPARC to

Fundamental Analysis

Sun Pharma Advanced Research Co Ltd
NSE:SPARC
IN
Pharmaceuticals
Market Cap
54.5B INR
IPO
Jul 18, 2007
IN
Pharmaceuticals
Market Cap
54.5B INR
IPO
Jul 18, 2007
Price
₹false
EPS
₹false
Sun Pharma Advanced Research Co Ltd
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about SPARC?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Sun Pharma Advanced Research Co Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Sun Pharma Advanced Research Co Ltd

Current Assets 261.9m
Cash & Short-Term Investments 43.2m
Receivables 162.2m
Other Current Assets 56.5m
Non-Current Assets 3.1B
Long-Term Investments 261.1m
PP&E 992.6m
Intangibles 536.5m
Other Non-Current Assets 1.3B
Efficiency

Free Cash Flow Analysis
Sun Pharma Advanced Research Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Sun Pharma Advanced Research Co Ltd

Revenue
717.7m INR
Cost of Revenue
-231.2m INR
Gross Profit
486.5m INR
Operating Expenses
-3.8B INR
Operating Income
-3.4B INR
Other Expenses
-69.8m INR
Net Income
-3.4B INR
Fundamental Scores

SPARC Profitability Score
Profitability Due Diligence

Sun Pharma Advanced Research Co Ltd's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Gross Profit
Exceptional ROE
ROE is Increasing
39/100
Profitability
Score

Sun Pharma Advanced Research Co Ltd's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

SPARC Solvency Score
Solvency Due Diligence

Sun Pharma Advanced Research Co Ltd's solvency score is 20/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Positive Net Debt
Short-Term Solvency
20/100
Solvency
Score

Sun Pharma Advanced Research Co Ltd's solvency score is 20/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SPARC Price Targets Summary
Sun Pharma Advanced Research Co Ltd

There are no price targets for SPARC.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Sun Pharma Advanced Research Co Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for SPARC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

SPARC Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one SPARC stock?

The intrinsic value of one SPARC stock under the Base Case scenario is 1 382.17 INR.

Is SPARC stock undervalued or overvalued?

Compared to the current market price of 168.09 INR, Sun Pharma Advanced Research Co Ltd is Undervalued by 88%.

Back to Top